Health Insurance Policy Review Committee members are asking for face-to-face examination of 'Stillen'

Domestic natural product drug 'Stillen' which was danger of being restricted in insurance benefit, turned the corner. It is because Health Insurance Policy Review Committee members are asking for face-to-face examination, and the government decided to accept the request.

If Health Insurance Policy Review Committee members accept the request of Donga Pharmaceutical and reject agenda of insuranc...